logo

For the Inventor, By the Inventor

Raleigh, NC, United States of America

Scott Lyman

This inventor holds 15 USPTO granted patents and 15 published patent applications, primarily in Pharmaceutical Formulations. Top assignee: Belhaven Biopharma, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Lyman. Retrieved from https://idiyas.com/inventor/scott-lyman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 40.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:

goldMedal15 out of 17 
 
Belhaven Biopharma, Inc.
 patents

Years Active: 2023-2026

Loading Chart...
Areas of Expertise:
Epinephrine
Dry Powder Formulations
Intranasal Delivery
Medical Countermeasures
Compositions
Devices
Methods
Pharmaceuticals
15 patents (USPTO):Explore Patents
1. 12779152 - Dry powder formulations of epinephrine and associated methods (2026-11-03),
2. 12728092 - Dry powder formulations of epinephrine and associated methods (2026-09-08),
3. 12678574 - Compositions, devices, and methods for intranasal delivery of dry powder epinephrine (2026-07-14),
4. 12678404 - Dry powder formulations of epinephrine and associated methods (2026-07-14),
5. 12661315 - Dry powder formulations of epinephrine and associated methods (2026-06-23),
6. 12653972 - Compositions, devices, and methods for intranasal delivery of dry powder epinephrine (2026-06-16),
7. 12653778 - Dry powder formulations of epinephrine and associated methods (2026-06-16),
8. 12616807 - Medical counter measures including dry powder formulations and associated methods (2026-05-05),
9. 12605517 - Compositions, devices, and methods for intranasal delivery of dry powder epinephrine (2026-04-21),
10. 12502498 - Compositions, devices, and methods for intranasal delivery of dry powder epinephrine (2025-12-23),
11. 12414916 - Dry powder formulations of epinephrine and associated methods (2025-09-16),
12. 12097287 - Dry powder formulations of epinephrine and associated methods (2024-09-24),
13. 12005185 - Medical counter measures including dry powder formulations and associated methods (2024-06-11),
14. 11872308 - Dry powder formulations of epinephrine and associated methods (2024-01-16),
15. 11617716 - Dry powder formulations of epinephrine and associated methods (2023-04-04),

Title: Scott Lyman: Innovator in Dry Powder Formulations

Introduction

Scott Lyman is a notable inventor based in Raleigh, NC, who has made significant contributions to the field of pharmaceutical formulations. With a total of five patents to his name, Lyman has focused on developing innovative solutions for critical medical conditions.

Latest Patents

Among his latest patents, Lyman has developed dry powder formulations of epinephrine. These formulations are designed for nasal application and include epinephrine alone or in combination with at least one enabling agent. The unit dose forms and devices created from these formulations are intended for the treatment of various conditions, including anaphylaxis, anaphylactoid reactions, respiratory conditions, hemodynamic collapse, and for administration during cardiopulmonary arrest and other life-threatening situations.

Career Highlights

Lyman's career is marked by his dedication to advancing medical treatments through innovative formulations. His work has the potential to improve patient outcomes in emergency situations, showcasing his commitment to public health.

Collaborations

Throughout his career, Lyman has collaborated with notable colleagues, including Barry Bleske and Ted William Lanpher. These partnerships have contributed to the development and refinement of his innovative formulations.

Conclusion

Scott Lyman's contributions to the field of pharmaceutical innovations, particularly in dry powder formulations of epinephrine, highlight his role as a significant inventor. His work continues to pave the way for advancements in emergency medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…